Perna ER, Cimbaro Canella JP, Coronel ML, et al. Overview of Heart Failure in Argentina. En: Baliga RR, Haas GJ (dds). Management of Heart Failure. Volume I: Medical. (Second edition). London 2015. Springer-Verlag. 287-304.Perna E, Cimbaro Canela J, Coronel M, Echazarreta D. ...
Heart failure is a final common pathway in cardiovascular disease, as a result of sustained pressure overload (i.e., hypertension), myocardial ischemia or infarction, volume overload (i.e., mitral regurgitation), or inherited and acquired cardiomyopathies. Heart failure is a major health care...
Sotagliflozin (Inpefa) is an orally administered dual SGLT1/2 inhibitor that reduces the risk of death due to heart failure. The FDA approved sotagliflozin (Inpefa) in May 2023 for the purpose of lowering the risk of cardiovascular death and heart failure in adult patients with heart failure...
Hyponatremia and heart failure--pathophysiology and implications. Fluid and electrolyte disturbances are a common feature of heart failure. Among the electrolyte disturbances that occur in heart failure, disorders of potassium and magnesium have traditionally received the most attention. Abnormalities ... ...
Chronic heart failure: an overview of conven- tional treatment versus novel approaches. Nat Clin Prac Cardiovasc Med 2005;2:628-638.Landmesser U and Drexler H. Chronic heart failure: an overview of conventional treatment versus novel approaches. Nat Clin Pract Cardiovasc Med. 2005; 2:628-38. ...
左心室射血分数保留心力衰竭(Heart failure with preserved left ventricular ejection fraction, HFpEF)是指临床具有心力衰竭的症状或体征,且左心室射血分数(LVEF) ≥ 50%的一种综合征.中医药在改善患者症状,提高生命质量等方面有较好疗效,本文从病因病机,辨证分型及治疗进展方面论述了目前中医学对射血分数保留心力衰...
Heart failure in the adult can be due to various causes, includinghypertrophic cardiomyopathy, hypertensive orvalvular heart disease, and idiopathic cardiomyopathy. Determining whether leftventricular dysfunctionis due to the consequences ofCADor other causes is critical for patient management. If...
Inter-firm R&D partnerships: an overview of major trends and patterns since 1960 No abstract is available for this item. J Hagedoorn 被引量: 2555发表: 2002年 Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure No abstr...
Heart failure, when your heart can't pump enough blood and oxygen to support your other organs. Atherosclerosis of your aorta, when you have a buildup of fat, calcium, and cholesterol deposits on the inside of your aorta. Aortic aneurym, when you have a ballooning where your aorta attaches...
heart transplantation; ex-vivo normothermic perfusion; organ care system; cold ischemic time; hypothermic perfusion1. Introduction End-stage heart failure is the leading cause of mortality among all organ failures worldwide [1]. At present, heart transplantation (HT) remains the gold standard for...